Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion – Results from the 2SMART phase 2 trial
Wee Loon Ong, Patrick Cheung, Hans T. Chung, William Chu, Jay Detsky, Stanley K. Liu, Gerard Morton, Ewa Szumacher, Chia‐Lin Tseng, Danny Vesprini, Melanie Davidson, Ananth Ravi, Merrylee McGuffin, Liying Zhang, Alexandre Mamedov, Andrea Deabreu, Meghan Kulasingham-Poon, Andrew Loblaw
Topics & Concepts
MedicineSABR volatility modelProstate cancerProstateAblative caseRadiation therapyMagnetic resonance imagingRadiosurgeryUrologyClinical endpointNuclear medicineRadiologyCancerSurgeryInternal medicineRandomized controlled trialEconomicsVolatility (finance)Stochastic volatilityFinancial economicsProstate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesProstate Cancer Treatment and Research